Sugi Predict

Sugi Predict / Compounds / SCHEMBL332471

SCHEMBL332471

SCHEMBL332471

CNC(=O)C1(c2cc(F)cc(Sc3ccc(-c4ccnn4C)cc3)c2F)CCOCC1

nearest known ligand 0.54

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ ALOX5 P09917 4/20 0.54
▸ CD274 Q9NZQ7 1/20 0.36
▸ AKT1 P31749 7/20 0.36
▸ AKT2 P31751 4/20 0.35
▸ AXL P30530 1/20 0.33
▸ HDAC4 P56524 1/20 0.33
▸ P2RX7 Q99572 1/20 0.33
▸ ABL1 P00519 1/20 0.33
▸ MMP1 P03956 1/20 0.32
▸ MMP13 P45452 1/20 0.32
▸ HDAC9 Q9UKV0 2/20 0.32
▸ SGK1 O00141 2/20 0.32
▸ RPS6KB1 P23443 2/20 0.32
▸ PRKCQ Q04759 2/20 0.32
▸ ROCK1 Q13464 2/20 0.32
▸ RPS6KA1 Q15418 2/20 0.32
▸ AKT3 Q9Y243 2/20 0.32
▸ ROCK2 O75116 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL332324 0.89 ALOX5 (0.66) ALOX5CD274AKT1AKT2AXL
SCHEMBL331664 0.88 ALOX5 (0.55) ALOX5CD274AKT1AXLHDAC4
SCHEMBL332390 0.84 ALOX5 (0.61) ALOX5CD274AKT1AKT2AXL
SCHEMBL332628 0.78 ALOX5 (0.63) ALOX5CD274P2RX7ABL1
SCHEMBL332517 0.77 ALOX5 (0.67) ALOX5CD274AKT1HDAC4P2RX7
SCHEMBL332862 0.74 ALOX5 (0.78) ALOX5CD274AKT1AKT2P2RX7
SCHEMBL332240 0.73 ALOX5 (0.76) ALOX5CD274AKT1AKT2HDAC4
SCHEMBL10193056 0.72 ALOX5 (0.48) ALOX5CD274AKT1P2RX7ABL1
SCHEMBL332778 0.72 ALOX5 (0.67) ALOX5CD274AKT1AKT2HDAC4
SCHEMBL3660567 0.69 ALOX5 (0.46) ALOX5CD274HDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090227634-A1 Pyrazole Derivatives as 5-LO-Inhibitors PFIZER INC. 2009-09-10 — — US claimed
US-8097733-B2 Pyrazole derivatives as 5-LO-inhibitors PFIZER INC. (US) 2012-01-17 — — US disclosed
US-8097733-B2 Pyrazole derivatives as 5-LO-inhibitors PFIZER INC. (US) 2012-01-17 — — US disclosed
US-8097733-B2 Pyrazole derivatives as 5-LO-inhibitors PFIZER INC. (US) 2012-01-17 — — US disclosed
EP-2225229-A1 PYRAZOLE DERIVATIVES AS 5-LO INHIBITORS Pfizer Inc. (US) 2010-09-08 — — EP disclosed
US-20090227634-A1 Pyrazole Derivatives as 5-LO-Inhibitors PFIZER INC. 2009-09-10 — — US disclosed
US-20090227634-A1 Pyrazole Derivatives as 5-LO-Inhibitors PFIZER INC. 2009-09-10 — — US disclosed
US-20090227634-A1 Pyrazole Derivatives as 5-LO-Inhibitors PFIZER INC. 2009-09-10 — — US disclosed
WO-2009069044-A1 PYRAZOLE DERIVATIVES AS 5-LO INHIBITORS PFIZER INC. (US) 2009-06-04 — — WO disclosed
WO-2009069044-A1 PYRAZOLE DERIVATIVES AS 5-LO INHIBITORS PFIZER INC. (US) 2009-06-04 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090227634-A1 Pyrazole Derivatives as 5-LO-Inhibitors ALOX5, ALOX15, CYP3A5 ALOX5 1/4885CD274 2601/4885AKT1 3057/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.